Related Experiment Video
Updated: Sep 17, 2025
09:52
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
13.5K
Radiation Therapy for Metastatic Melanoma
Lauren DeBusk1, Angela Rosenberg1, Joshua Burshtein2
1Department of Dermatology, University of Texas Southwestern Medical Center, 5959 Harry Hines Boulevard 4th Floor Suite 100, Dallas, TX 75390, USA.
Dermatologic Clinics
|June 28, 2025
Summary
Metastatic melanoma, a resistant skin cancer, shows improved outcomes when radiation therapy (RT) is combined with immune checkpoint inhibitors (ICIs). Research explores RT
Area of Science:
- Oncology
- Radiation Oncology
- Immunotherapy
Background:
- Metastatic melanoma is an aggressive skin cancer with poor prognosis.
- Historically, melanoma was considered radioresistant.
- Advances integrate radiation therapy (RT) with systemic treatments like immune checkpoint inhibitors (ICIs).
Purpose of the Study:
- To explore the evolving role of RT in metastatic melanoma.
- To highlight the synergy between RT and ICIs.
- To discuss ongoing research for optimizing treatment outcomes.
Main Methods:
- Review of current literature on RT and ICIs in metastatic melanoma.
- Analysis of RT's established roles (local control, palliative care, brain metastases).
- Exploration of RT-ICI synergy mechanisms, including the abscopal effect.
Main Results:
- RT is increasingly effective in metastatic melanoma, particularly with ICIs.
- Evidence supports RT's role in local control and managing specific metastatic sites.
- The abscopal effect demonstrates potential systemic benefits of RT when combined with immunotherapy.
Conclusions:
- RT is a valuable component in the multimodal treatment of metastatic melanoma.
- Combining RT with ICIs offers synergistic therapeutic potential.
- Further research is crucial to refine RT strategies and improve patient survival rates.
